Moody's upgrades Biogen (BIIB) from Baa3 to Baa2; outlook Stable
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Join SI Premium – FREE
Moody's upgrades Biogen (Nasdaq: BIIB) from Baa3 to Baa2; outlook Stable
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) call put ratio 3.7 calls to 1 put with a focus on September calls
- Ferrovial SA (FER:SM) (FRRVF) Reiterated at Buy by UBS on Winning Bid For Tennessee Project
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
Credit RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
